Keyphrases
Vortioxetine
100%
Intermittent Cold Stress
100%
5-HT Depletion
100%
Reversal Learning
100%
Cognitive Flexibility
33%
5-HT Receptors
33%
Learning Impairment
22%
Selective Serotonin Reuptake Inhibitors
22%
5-hydroxytryptamine
22%
Reuptake
22%
Spontaneous Excitatory Postsynaptic Current (sEPSC)
22%
Receptor Activation
11%
Prefrontal Cortex
11%
Methyl Ester
11%
High Incidence
11%
Current Treatment
11%
Receptor Antagonist
11%
Stress-induced
11%
Residual Symptoms
11%
Depression Risk
11%
Chronic Stress
11%
Antidepressants
11%
Serotonin 5-HT
11%
5-HT1A Receptor Agonist
11%
5-HT Transporter
11%
5-HT3
11%
5-HT1D Receptor
11%
5-HT1B Receptor
11%
5-HT7
11%
Partial Agonist
11%
Pharmacological Effects
11%
4-chloro-DL-phenylalanine
11%
Dietary Administration
11%
Inhibitor Treatment
11%
Subchronic
11%
Treatment for Depression
11%
Residual Treatment
11%
Treatment Resistance
11%
Adult Male Rats
11%
Dysregulation
11%
Hydrochloride
11%
Neuroscience
Vortioxetine
100%
Learning Disabilities
100%
Cognitive Flexibility
33%
5-HT Receptor
33%
Selective Serotonin Reuptake Inhibitor
22%
Reuptake
22%
Fenclonine
22%
Prefrontal Cortex
11%
Chloride
11%
Receptor Antagonist
11%
Serotonin
11%
Antidepressant
11%
Receptor Partial Agonist
11%
Serotonin Transporter
11%
5-HT1B Receptor
11%
Receptor Agonists
11%
5-HT1D Receptor
11%
5-HT1A Receptor
11%
Phenylalanine Methyl Ester
11%
Pharmacology, Toxicology and Pharmaceutical Science
Vortioxetine
100%
Learning Disorder
100%
Receptor
33%
Selective Serotonin Reuptake Inhibitor
22%
Fenclonine
22%
Receptor Agonist
11%
Partial Agonist
11%
Serotonin
11%
Serotonin Transporter
11%
Antidepressant
11%
Serotonin 1D Antagonist
11%
Chloride
11%
Phenylalanine Methyl Ester
11%